Latest News

New compound to treat depression identified

A compound, hydroxynorketamine (HNK), has been identified by researchers that may treat symptoms of depression just as effectively and rapidly as ketamine, without the unwanted side effects associated with the psychoactive drug, according to a study. Interestingly, use of HNK may also serve as a future therapeutic approach for treating neurodegenerative disorders such as Alzheimer's and Parkinson's diseases, the authors note.
View full story

Post your comment.

Name:
Email:
Rating:
Comment:
Verification
 

  • Borderline personality traits linked to lowered empathy

  • Medicinal marijuana: Patients battle stigma and misunderstanding

  • Cannabis and the brain

  • Awareness of memory loss may decline two-three years before dementia onset

  • About 10 percent of mothers experienced depression two years after Hurricane Katrina

  • Alzheimer?s disease thought to be accelerated by an abnormal build-up of fat in the brain

  • Parkinson?s disease brain cells at risk of burnout, like an overheating motor

  • Creative and neurotic: Is neuroticism fueled by overthinking?

  • Suicide: Difficulty making good choices is one of the factors that make certain people vulnerable to suicide

  • Nasal spray device for mental illness

  •